Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 81734D104 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Third Rock Ventures V, L.P.
13G/A
|
14.0% |
5/9/2025
Event 3/31/2025
|
||
| Third Rock Ventures V, L.P. | 14.0% | |||
| Third Rock Ventures GP V, L.P. | 14.0% | |||
| TRV GP V, LLC | 14.0% | |||
| Third Rock Ventures VI, L.P. | 9.5% | |||
| Third Rock Ventures GP VI, L.P. | 9.5% | |||
| TRV GP VI, LLC | 9.5% | |||
|
RA Capital Management, L.P.
13D/A
|
11.8% |
8/14/2026
Event 8/12/2026
|
||
| RA Capital Management, L.P. | 11.8% | |||
| Peter Kolchinsky | 11.8% | |||
| Rajeev Shah | 11.8% | |||
| RA Capital Healthcare Fund, L.P. | 10.2% | |||
| Driehaus Capital Management LLC 13G/A | 9.8% |
8/14/2026
Event 6/30/2026
|
||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (1) | ||||
|
Biotechnology Value Fund L P
13G/A
|
3.8% |
2/17/2026
Event 12/31/2025
|
||
| Biotechnology Value Fund L P | 2.0% | |||
| BVF I GP LLC | 2.0% | |||
| Biotechnology Value Fund II LP | 1.5% | |||
| BVF II GP LLC | 1.5% | |||
| Biotechnology Value Trading Fund OS LP | 0.2% | |||
| BVF Partners OS Ltd. | 0.2% | |||
| BVF GP Holdings LLC | 3.6% | |||
| BVF Partners L P/IL | 3.8% | |||
| BVF Inc/IL | 3.8% | |||
| Lampert Mark N | 3.8% | |||